Published in PLoS One on July 28, 2009
Diversity, stability and resilience of the human gut microbiota. Nature (2012) 9.09
Gut microbiota composition correlates with diet and health in the elderly. Nature (2012) 6.94
Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology (2010) 2.30
The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology (2011) 2.18
Computational meta'omics for microbial community studies. Mol Syst Biol (2013) 1.84
Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's disease. PLoS One (2012) 1.84
Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. Mol Cell Proteomics (2011) 1.81
The human microbiome and its potential importance to pediatrics. Pediatrics (2012) 1.74
Role of the gut microbiota in defining human health. Expert Rev Anti Infect Ther (2010) 1.73
Effect of antibiotic treatment on the intestinal metabolome. Antimicrob Agents Chemother (2011) 1.64
The function of our microbiota: who is out there and what do they do? Front Cell Infect Microbiol (2012) 1.54
Biodiversity and functional genomics in the human microbiome. Trends Genet (2012) 1.52
Metabolomics in epidemiology: sources of variability in metabolite measurements and implications. Cancer Epidemiol Biomarkers Prev (2013) 1.50
Investigating the biological and clinical significance of human dysbioses. Trends Microbiol (2011) 1.48
High-fat diet alters gut microbiota physiology in mice. ISME J (2013) 1.44
Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study. PLoS One (2016) 1.39
A metagenomic β-glucuronidase uncovers a core adaptive function of the human intestinal microbiome. Proc Natl Acad Sci U S A (2010) 1.33
Integrative analysis of the microbiome and metabolome of the human intestinal mucosal surface reveals exquisite inter-relationships. Microbiome (2013) 1.32
Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4. Immunity (2014) 1.28
Gut microbial gene expression in mother-fed and formula-fed piglets. PLoS One (2010) 1.27
Functional analysis of colonic bacterial metabolism: relevant to health? Am J Physiol Gastrointest Liver Physiol (2011) 1.21
Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals. J Proteome Res (2012) 1.21
Metabolomic analysis in severe childhood pneumonia in the Gambia, West Africa: findings from a pilot study. PLoS One (2010) 1.19
Identification of noninvasive biomarkers for alcohol-induced liver disease using urinary metabolomics and the Ppara-null mouse. J Proteome Res (2010) 1.13
Distinct signatures of host-microbial meta-metabolome and gut microbiome in two C57BL/6 strains under high-fat diet. ISME J (2014) 1.13
Impact of salmonella infection on host hormone metabolism revealed by metabolomics. Infect Immun (2011) 1.12
Enteric pathogen exploitation of the microbiota-generated nutrient environment of the gut. Curr Opin Microbiol (2011) 1.09
Comparison of different assembly and annotation tools on analysis of simulated viral metagenomic communities in the gut. BMC Genomics (2014) 1.07
Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions. Genome Med (2016) 1.05
Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery. Drug Discov Today (2013) 1.03
From meta-omics to causality: experimental models for human microbiome research. Microbiome (2013) 1.02
Mass spectrometry-based quantitative metabolomics revealed a distinct lipid profile in breast cancer patients. Int J Mol Sci (2013) 1.02
Modeling the impact of antibiotic exposure on human microbiota. Sci Rep (2014) 1.01
Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD. Am J Gastroenterol (2016) 1.00
Statistical methods for the analysis of high-throughput metabolomics data. Comput Struct Biotechnol J (2013) 1.00
Genome-wide multi-omics profiling of colorectal cancer identifies immune determinants strongly associated with relapse. Front Genet (2013) 0.99
The opposing forces of the intestinal microbiome and the emerging pathobiome. Surg Clin North Am (2014) 0.98
Microbiota and metabolite profiling reveal specific alterations in bacterial community structure and environment in the cystic fibrosis airway during exacerbation. PLoS One (2013) 0.97
Clinical metabolomics paves the way towards future healthcare strategies. Br J Clin Pharmacol (2013) 0.95
Serum metabolomics in a Helicobacter hepaticus mouse model of inflammatory bowel disease reveal important changes in the microbiome, serum peptides, and intermediary metabolism. J Proteome Res (2012) 0.95
Responders and non-responders to probiotic interventions: how can we improve the odds? Gut Microbes (2011) 0.94
Recent advances of metabolomics in plant biotechnology. Plant Biotechnol Rep (2011) 0.93
Microbiome-wide association studies link dynamic microbial consortia to disease. Nature (2016) 0.93
Metabolomics enables precision medicine: "A White Paper, Community Perspective". Metabolomics (2016) 0.93
Bovine immunoglobulin protein isolates for the nutritional management of enteropathy. World J Gastroenterol (2014) 0.92
1H-NMR based metabonomic profiling of human esophageal cancer tissue. Mol Cancer (2013) 0.92
Insulin sensitivity is reflected by characteristic metabolic fingerprints--a Fourier transform mass spectrometric non-targeted metabolomics approach. PLoS One (2010) 0.90
Application of metagenomics in the human gut microbiome. World J Gastroenterol (2015) 0.90
Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosis. Sci Rep (2015) 0.88
Functional metagenomic investigations of the human intestinal microbiota. Front Microbiol (2011) 0.88
Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics (2014) 0.87
Metabolomic analysis of human disease and its application to the eye. J Ocul Biol Dis Infor (2009) 0.87
Metabolomic applications to decipher gut microbial metabolic influence in health and disease. Front Physiol (2012) 0.87
Metabolomics as a diagnostic tool in gastroenterology. World J Gastrointest Pharmacol Ther (2013) 0.87
A Disease-Associated Microbial and Metabolomics State in Relatives of Pediatric Inflammatory Bowel Disease Patients. Cell Mol Gastroenterol Hepatol (2016) 0.87
Short-chain fructo-oligosaccharides modulate intestinal microbiota and metabolic parameters of humanized gnotobiotic diet induced obesity mice. PLoS One (2013) 0.86
Identification of urinary biomarkers of colon inflammation in IL10-/- mice using Short-Column LCMS metabolomics. J Biomed Biotechnol (2010) 0.86
Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases. Mol Nutr Food Res (2016) 0.85
The role of the immune system in regulating the microbiota. Gut Microbes (2010) 0.85
Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human Health. Front Microbiol (2016) 0.83
Metabolomics: is it useful for inflammatory bowel diseases? Curr Opin Gastroenterol (2013) 0.82
Diagnostic and Prognostic Microbial Biomarkers in Inflammatory Bowel Diseases. Gastroenterology (2015) 0.82
Profiles of Microbial Fatty Acids in the Human Metabolome are Disease-Specific. Front Microbiol (2011) 0.81
Integration of datasets from different analytical techniques to assess the impact of nutrition on human metabolome. Front Cell Infect Microbiol (2012) 0.81
Mass spectrometry-based metabolomics, analysis of metabolite-protein interactions, and imaging. Biotechniques (2010) 0.81
An integrated lipidomics and metabolomics reveal nephroprotective effect and biochemical mechanism of Rheum officinale in chronic renal failure. Sci Rep (2016) 0.81
Metabolic profiling of the impact of oligofructose-enriched inulin in Crohn's disease patients: a double-blinded randomized controlled trial. Clin Transl Gastroenterol (2013) 0.80
NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer. Oncotarget (2016) 0.80
Advantages of tandem LC-MS for the rapid assessment of tissue-specific metabolic complexity using a pentafluorophenylpropyl stationary phase. J Proteome Res (2011) 0.80
Metabolonote: a wiki-based database for managing hierarchical metadata of metabolome analyses. Front Bioeng Biotechnol (2015) 0.80
Metabolic Model-Based Integration of Microbiome Taxonomic and Metabolomic Profiles Elucidates Mechanistic Links between Ecological and Metabolic Variation. mSystems (2016) 0.80
Harvesting the biological potential of the human gut microbiome. Bioessays (2011) 0.79
Chemical signaling in the gastrointestinal tract. F1000 Biol Rep (2011) 0.79
Metabolite Modulation in Human Plasma in the Early Phase of Acclimatization to Hypobaric Hypoxia. Sci Rep (2016) 0.79
Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. ISME J (2017) 0.78
Microbiome, Metabolome and Inflammatory Bowel Disease. Microorganisms (2016) 0.78
Urine metabolome profiling of immune-mediated inflammatory diseases. BMC Med (2016) 0.78
High-resolution characterization of the human microbiome. Transl Res (2016) 0.78
Stool phospholipid signature is altered by diet and tumors. PLoS One (2014) 0.78
Simultaneous Metabolite, Protein, Lipid Extraction (SIMPLEX): A Combinatorial Multimolecular Omics Approach for Systems Biology. Mol Cell Proteomics (2016) 0.77
Doping control using high and ultra-high resolution mass spectrometry based non-targeted metabolomics-a case study of salbutamol and budesonide abuse. PLoS One (2013) 0.77
Tools and databases of the KOMICS web portal for preprocessing, mining, and dissemination of metabolomics data. Biomed Res Int (2014) 0.76
Gut microbiome in chronic kidney disease: challenges and opportunities. Transl Res (2016) 0.76
Unique β-Glucuronidase Locus in Gut Microbiomes of Crohn's Disease Patients and Unaffected First-Degree Relatives. PLoS One (2016) 0.76
(1)H NMR-based metabolic profiling reveals inherent biological variation in yeast and nematode model systems. J Biomol NMR (2011) 0.76
The Features of Fecal and Ileal Mucosa-Associated Microbiota in Dairy Calves during Early Infection with Mycobacterium avium Subspecies paratuberculosis. Front Microbiol (2016) 0.76
Diversity of Gut Microbiota Metabolic Pathways in 10 Pairs of Chinese Infant Twins. PLoS One (2016) 0.75
Biomarkers are used to predict quantitative metabolite concentration profiles in human red blood cells. PLoS Comput Biol (2017) 0.75
Emerging role of novel biomarkers in the diagnosis of inflammatory bowel disease. World J Gastrointest Pharmacol Ther (2016) 0.75
Unravelling the metabolic impact of SBS-associated microbial dysbiosis: Insights from the piglet short bowel syndrome model. Sci Rep (2017) 0.75
A multi-omic future for microbiome studies. Nat Microbiol (2016) 0.75
Urinary metabolites as noninvasive biomarkers of gastrointestinal diseases: A clinical review. World J Gastrointest Oncol (2016) 0.75
Xenobiotic Receptor-Mediated Regulation of Intestinal Barrier Function and Innate Immunity. Nucl Receptor Res (2016) 0.75
Metabolomic Approaches to Explore Chemical Diversity of Human Breast-Milk, Formula Milk and Bovine Milk. Int J Mol Sci (2016) 0.75
High-Throughput Metabolic Profiling of Soybean Leaves by Fourier Transform Ion Cyclotron Resonance Mass Spectrometry. Anal Chem (2015) 0.75
In vitro microbiotic fermentation causes an extensive metabolite turnover of rye bran phytochemicals. PLoS One (2012) 0.75
Comparison of Collection Methods for Fecal Samples for Discovery Metabolomics in Epidemiologic Studies. Cancer Epidemiol Biomarkers Prev (2016) 0.75
Microbiomarkers in inflammatory bowel diseases: caveats come with caviar. Gut (2017) 0.75
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A (2008) 14.18
A simple index of Crohn's-disease activity. Lancet (1980) 11.12
Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet (2007) 8.63
Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol (2006) 7.75
Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A (2008) 6.42
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A (2009) 5.86
Human metabolic phenotype diversity and its association with diet and blood pressure. Nature (2008) 5.41
Gut microorganisms, mammalian metabolism and personalized health care. Nat Rev Microbiol (2005) 5.35
Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet (1991) 5.02
Shotgun metaproteomics of the human distal gut microbiota. ISME J (2008) 3.43
Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J (2008) 2.96
Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis (2009) 2.85
Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology (2003) 2.57
MassTRIX: mass translator into pathways. Nucleic Acids Res (2008) 2.05
Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res (2007) 1.99
Protein tyrosine phosphatases in autoimmunity. Annu Rev Immunol (2008) 1.90
Molecular classification of Crohn's disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells. J Mol Diagn (2006) 1.89
The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23-->IL-17 axis. J Immunol (2007) 1.87
Species variation in the fecal metabolome gives insight into differential gastrointestinal function. J Proteome Res (2007) 1.30
Metabolic evidence for biogeographic isolation of the extremophilic bacterium Salinibacter ruber. ISME J (2008) 1.26
Inflammatory-mediated repression of the rat ileal sodium-dependent bile acid transporter by c-fos nuclear translocation. Gastroenterology (2002) 1.06
Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease. Dig Dis Sci (2002) 1.04
Human fecal water inhibits COX-2 in colonic HT-29 cells: role of phenolic compounds. J Nutr (2005) 0.93
Gallbladder bile composition in patients with Crohn 's disease. World J Gastroenterol (2006) 0.92
Changes in mucosal fatty acid profile in inflammatorybowel disease and in experimental colitis: a common response to bowel inflammation. Clin Nutr (1997) 0.89
Serum tryptophan in Crohn's disease. Scand J Gastroenterol (1976) 0.87
Arachidonic acid but not eicosapentaenoic acid (EPA) and oleic acid activates NF-kappaB and elevates ICAM-1 expression in Caco-2 cells. Lipids (2007) 0.87
Dopamine D2 receptor polymorphisms in inflammatory bowel disease and the refractory response to treatment. Dig Dis Sci (2006) 0.85
Human intestinal cell monolayers are preferentially sensitive to disruption of barrier function from basolateral exposure to cholic acid: correlation with membrane transport and transepithelial secretion. Pflugers Arch (2001) 0.82
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet (2010) 17.38
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 7.98
DNA methylation profiles in monozygotic and dizygotic twins. Nat Genet (2009) 5.99
Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet (2011) 5.58
CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet (2002) 5.31
A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology (2010) 5.29
Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet (2010) 4.65
Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol (2010) 4.52
Shotgun metaproteomics of the human distal gut microbiota. ISME J (2008) 3.43
Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease. Nat Genet (2010) 3.22
Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J (2008) 2.96
Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis (2009) 2.85
Appendectomy is followed by increased risk of Crohn's disease. Gastroenterology (2003) 2.62
Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology (2003) 2.57
MassTRIX: mass translator into pathways. Nucleic Acids Res (2008) 2.05
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics (2010) 1.90
Geographical variability and environmental risk factors in inflammatory bowel disease. Gut (2013) 1.84
Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's disease. PLoS One (2012) 1.84
Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies. Gastroenterology (2013) 1.83
Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Inflamm Bowel Dis (2006) 1.73
Soft inertial microfluidics for high throughput separation of bacteria from human blood cells. Lab Chip (2009) 1.63
The dynamic range of the human metabolome revealed by challenges. FASEB J (2012) 1.61
CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics Clin Appl (2008) 1.57
The dosage of small volumes for chromatographic quantifications using a drop-on-demand dispenser system. Anal Bioanal Chem (2007) 1.41
Response of Arabidopsis thaliana to N-hexanoyl-DL-homoserine-lactone, a bacterial quorum sensing molecule produced in the rhizosphere. Planta (2008) 1.35
Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis. PLoS Genet (2013) 1.34
Combined polymorphisms in genes encoding the inflammasome components NALP3 and CARD8 confer susceptibility to Crohn's disease in Swedish men. Am J Gastroenterol (2009) 1.26
Metabolic evidence for biogeographic isolation of the extremophilic bacterium Salinibacter ruber. ISME J (2008) 1.26
Physical heterogeneity increases biofilm resource use and its molecular diversity in stream mesocosms. PLoS One (2010) 1.25
Preanalytical aspects and sample quality assessment in metabolomics studies of human blood. Clin Chem (2013) 1.24
Metabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traits. Metabolomics (2010) 1.24
CD98 expression modulates intestinal homeostasis, inflammation, and colitis-associated cancer in mice. J Clin Invest (2011) 1.23
Fine-scale evolution: genomic, phenotypic and ecological differentiation in two coexisting Salinibacter ruber strains. ISME J (2010) 1.17
Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: the first 100 patients treated in Scandinavia. Scand J Gastroenterol (2007) 1.14
The Arabidopsis glucosyltransferase UGT76B1 conjugates isoleucic acid and modulates plant defense and senescence. Plant Cell (2011) 1.13
The Short Health Scale: a valid measure of subjective health in ulcerative colitis. Scand J Gastroenterol (2006) 1.10
The chemodiversity of wines can reveal a metabologeography expression of cooperage oak wood. Proc Natl Acad Sci U S A (2009) 1.09
Unraveling different chemical fingerprints between a champagne wine and its aerosols. Proc Natl Acad Sci U S A (2009) 1.07
IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease. BMC Med Genet (2009) 1.06
PepT1 oligopeptide transporter (SLC15A1) gene polymorphism in inflammatory bowel disease. Inflamm Bowel Dis (2009) 1.06
454 pyrosequencing analysis on faecal samples from a randomized DBPC trial of colicky infants treated with Lactobacillus reuteri DSM 17938. PLoS One (2013) 1.06
MassTRIX reloaded: combined analysis and visualization of transcriptome and metabolome data. PLoS One (2012) 1.06
Defining clinical criteria for clinical remission and disease activity in collagenous colitis. Inflamm Bowel Dis (2009) 1.05
Pathway analysis of the transcriptome and metabolome of salt sensitive and tolerant poplar species reveals evolutionary adaption of stress tolerance mechanisms. BMC Plant Biol (2010) 1.03
Uptake, degradation and chiral discrimination of N-acyl-D/L-homoserine lactones by barley (Hordeum vulgare) and yam bean (Pachyrhizus erosus) plants. Anal Bioanal Chem (2007) 1.02
Colonic mucosal tears in collagenous colitis. Scand J Gastroenterol (2006) 1.02
Microscopic colitis patients demonstrate a mixed Th17/Tc17 and Th1/Tc1 mucosal cytokine profile. Mol Immunol (2013) 1.02
Worries and concerns in a large unselected cohort of patients with Crohn's disease. Scand J Gastroenterol (2010) 1.01
Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study. Inflamm Bowel Dis (2011) 1.00
Is smoking a risk factor for collagenous colitis? Scand J Gastroenterol (2011) 0.99
Automated label-free quantification of metabolites from liquid chromatography-mass spectrometry data. Mol Cell Proteomics (2013) 0.98
Short health scale: a valid, reliable, and responsive instrument for subjective health assessment in Crohn's disease. Inflamm Bowel Dis (2008) 0.96
Metabolic profiles and genetic diversity of denitrifying communities in activated sludge after addition of methanol or ethanol. Appl Environ Microbiol (2006) 0.95
Serum 27-nor-5β-cholestane-3,7,12,24,25 pentol glucuronide discovered by metabolomics as potential diagnostic biomarker for epithelium ovarian cancer. J Proteome Res (2011) 0.95
Lactobacillus reuteri maintains a functional mucosal barrier during DSS treatment despite mucus layer dysfunction. PLoS One (2012) 0.95
Two new major subunits in the cellulosome of Clostridium thermocellum: xyloglucanase Xgh74A and endoxylanase Xyn10D. Microbiology (2005) 0.95
GC/MS-based metabolomics reveals fatty acid biosynthesis and cholesterol metabolism in cell lines infected with influenza A virus. Talanta (2010) 0.95
Variations of DOM quality in inflows of a drinking water reservoir: linking of van Krevelen diagrams with EEMF spectra by rank correlation. Environ Sci Technol (2012) 0.95
Inclusion of chicory (Cichorium intybus L.) in pigs' diets affects the intestinal microenvironment and the gut microbiota. Appl Environ Microbiol (2012) 0.95
Stable incidence of collagenous colitis and lymphocytic colitis in Örebro, Sweden, 1999-2008: a continuous epidemiologic study. Inflamm Bowel Dis (2013) 0.94
The influence of demographic and disease-related factors on health-related quality of life in patients with ulcerative colitis. Eur J Gastroenterol Hepatol (2003) 0.94
Distribution, abundance and diversity of the extremely halophilic bacterium Salinibacter ruber. Saline Systems (2008) 0.93
Pollen metabolome analysis reveals adenosine as a major regulator of dendritic cell-primed T(H) cell responses. J Allergy Clin Immunol (2011) 0.92
Colonic perforation in collagenous colitis: an unusual complication. Eur J Gastroenterol Hepatol (2005) 0.92
Health-related quality of life is impaired in active collagenous colitis. Dig Liver Dis (2010) 0.90
Insulin sensitivity is reflected by characteristic metabolic fingerprints--a Fourier transform mass spectrometric non-targeted metabolomics approach. PLoS One (2010) 0.90
Prevalence and trends in adult-type hypolactasia in different age cohorts in Central Sweden diagnosed by genotyping for the adult-type hypolactasia-linked LCT -13910C > T mutation. Scand J Gastroenterol (2007) 0.90
Liquid chromatography-mass spectrometry in metabolomics research: mass analyzers in ultra high pressure liquid chromatography coupling. J Chromatogr A (2013) 0.89
Mass spectrometric stereoisomeric differentiation between α- and β-ascorbic acid 2-O-glucosides. Experimental and density functional theory study. Rapid Commun Mass Spectrom (2011) 0.89
Analysis of 39 Crohn's disease risk loci in Swedish inflammatory bowel disease patients. Inflamm Bowel Dis (2010) 0.89
Microscopic colitis patients have increased proportions of Ki67(+) proliferating and CD45RO(+) active/memory CD8(+) and CD4(+)8(+) mucosal T cells. J Crohns Colitis (2012) 0.89
Exploration of intraclonal adaptation mechanisms of Pseudomonas brassicacearum facing cadmium toxicity. Environ Microbiol (2007) 0.89
Impact of lifestyle on the gut microbiota of healthy infants and their mothers—the ALADDIN birth cohort. FEMS Microbiol Ecol (2014) 0.89
RNAi-mediated suppression of isoprene emission in poplar transiently impacts phenolic metabolism under high temperature and high light intensities: a transcriptomic and metabolomic analysis. Plant Mol Biol (2010) 0.88
Hepatotoxicity by bosentan in a patient with portopulmonary hypertension: a case-report and review of the literature. J Gastrointestin Liver Dis (2011) 0.87
Colorectal cancer in patients with inflammatory bowel disease: can we predict risk? World J Gastroenterol (2012) 0.87
Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohort. Inflamm Bowel Dis (2014) 0.87
Phenotypic switching in Pseudomonas brassicacearum involves GacS- and GacA-dependent Rsm small RNAs. Appl Environ Microbiol (2012) 0.87
Identification of bacterial N-acylhomoserine lactones (AHLs) with a combination of ultra-performance liquid chromatography (UPLC), ultra-high-resolution mass spectrometry, and in-situ biosensors. Anal Bioanal Chem (2006) 0.87
Dynamic regulation of N-acyl-homoserine lactone production and degradation in Pseudomonas putida IsoF. FEMS Microbiol Ecol (2010) 0.87
Attachment of chloride anion to sugars: mechanistic investigation and discovery of a new dopant for efficient sugar ionization/detection in mass spectrometers. Chemistry (2012) 0.87
Susceptibility to Campylobacter infection is associated with the species composition of the human fecal microbiota. MBio (2014) 0.86
Long-term colectomy rate after intensive intravenous corticosteroid therapy for ulcerative colitis prior to the immunosuppressive treatment era. Am J Gastroenterol (2006) 0.86